Thomas Boulin

Thomas [dot] Boulin [at] univ-lyon1 [dot] fr

Favourite quote: Progress in science depends on new techniques, new discoveries and new ideas, probably in that order.
Sydney Brenner

Short Bio

Thomas Boulin heads the team "Molecular and cellular neurobiology of C. elegans" at the MeLiS laboratory - CNRS/INSERM/Université Lyon 1. He has worked with C. elegans for the past 25 years.

During his PhD with Oliver Hobert at Columbia University, he studied molecular and cellular mechanisms controling the formation and the maintenance of the C. elegans nervous system (Buelow, Neuron 2003). As a post-doc with Jean-Louis Bessereau at École Normale Supérieure in Paris, he developed genetic and electrophysiological strategies to study synaptic function and acetylcholine receptor modulation (Boulin, PNAS 2008 ; Boulin, Nature Neuroscience 2012).

His team is now focusing on the role played by potassium channels in the control of cellular excitability and the regulation of the cell's membrane potential. The goal of the team is to investigate the biology of these widely-conserved ion channels in their native cellular context by taking advantage of the powerful genetic tools available in C. elegans.

He has coordinated projects funded by the European Research Council (ERC Starting, 2013), AFM-Telethon, EU Horizon 2020, Fondation Maladies Rares, and Agence National pour la Recherche (ANR). Thomas Boulin is a recipient of the CNRS Bronze medal.

Thomas Boulin is also the founder and director of SEGiCel (UAR3453, Lyon), the sole IBiSA-certified national platform for CRISPR/Cas9 gene editing and transgenesis in C. elegans, which handles over 100 projects annually and has generated over 1000 CRISPR-edited lines to date.

Academic Positions & Education

Personal Funding & prizes

MeLiS | CNRS UMR 5284 | INSERM U1314
Université Claude Bernard Lyon 1
Faculté de Médecine - 3ème étage, aile D
8 avenue Rockefeller
69008 LYON
FRANCE
+33 4 26 68 82 82